Clinical Trial Update: Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating gemcitabine hydrochloride for pancreatic cancer that has been surgically removed, with the study status showing complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED